May 19, 2013 Too Many Questions Make This Thursday Mover a Sell - TheMotleyFool
May 18, 2013 1 Giant Leap for MannKind - TheMotleyFool
May 18, 2013 This Week in Biotech - TheMotleyFool
May 18, 2013 Will ASCO Unlock Big Value in This Cancer Drug Class? - TheMotleyFool
May 17, 2013 Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis - Pr Newswire
May 16, 2013 Finding the Next Big Blockbuster Drug - Accesswire-Tnw
May 16, 2013 Football Legend Jerome Bettis & Sanofi US Tackle Anaphylaxis During National Asthma and Allergy Awareness Month - Pr Newswire
May 16, 2013 The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals - Pr Newswire
May 15, 2013 Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA) - Pr Newswire
May 15, 2013 Sanofi and Regeneron`s Latest Partnership - TheMotleyFool
May 15, 2013 Sanofi, Regeneron Announce Patient Enrollment in Two Phase 3 Sarilumab Trials for Rheumatoid Arthritis - Benzinga
May 14, 2013 Sanofi (SNY) Showing Bullish Technicals But Could Break Through $55.38 Resistance - Freshbrewedmedia
May 14, 2013 Sanofi Smear Campaign to Limit Plavix Competition - YCharts
May 13, 2013 PatientsLikeMe and CISCRP Team up with Sanofi to Spotlight Medical Heroes and Clinical Trial Participation - Businesswire
May 12, 2013 1 Biotech`s Surprise Dilution Decoded - TheMotleyFool
May 10, 2013 MannKind`s Countdown to Liftoff? - TheMotleyFool
May 8, 2013 Obesity Drug Demand Still Low - TheMotleyFool
May 8, 2013 Sanofi (SNY) Showing Bullish Technicals But Could Fall Through $53.13 Support - Freshbrewedmedia
May 8, 2013 Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Lowest PEG Ratio - Benzinga
May 7, 2013 Double-Digit Returns from the Biotechnology Strategy - TheMotleyFool
May 7, 2013 The Zacks Analyst Blog Highlights: Bristol-Myers Squibb, Sanofi, AbbVie, Celgene and Telus - Pr Newswire
May 6, 2013 New Gold BondA? No Mess Powder Spray Introduced by Sanofi's Chattem - Pr Newswire
May 6, 2013 Sanofi US and Actress Elizabeth Perkins Premiere Documentary -- Diabetes Co-Stars Presents "Strength in Numbers" - Pr Newswire
May 4, 2013 3 Booming Biotech Companies - TheMotleyFool
May 4, 2013 Sanofi-AventisCorporate Event Announcement Notice - Wall Street Horizon
May 3, 2013 3 Promising Treatments for a Surprisingly Common Health Problem - TheMotleyFool
May 3, 2013 Regeneron Eyes 2 New Ophthalmology Treatments - TheMotleyFool
May 3, 2013 Regeneron Profit Skyrockets As Eylea Goes Blockbuster - Investors Business Daily
May 3, 2013 Regeneron Stock Soars On Q1 Results, Guidance Hike - Investors Business Daily
May 3, 2013 Shares of Sanofi-Aventis Have Risen Above Previous 52-Week High - Financial News Netwfork Online - 52-Week High-Lows
May 2, 2013 Regeneron Earnings Expected To Keep Booming - Investors Business Daily
May 2, 2013 Sanofi Gains As CEO Predicts Return To Topline Growth In H2 - Midnight Trader
May 2, 2013 Sanofi Q1 2013 - Interview with CFO Jerome Contamine - Businesswire
May 2, 2013 Sanofi-Aventis Makes a Move: Up 3.6% - Financial News Network Online - Market Movers
May 2, 2013 Sanofi: Q1 2013 business EPS(1) impacted by exclusivity losses in prior year - Pr Newswire
May 1, 2013 $50,000-a-Year MS Drugs: Pharma Growth Battle - YCharts
May 1, 2013 3 Pharma Stocks to Buy for the Long Run - TheMotleyFool
May 1, 2013 NextBio signs translational medicine collaboration with Sanofi for research and clinical applications - M2
May 1, 2013 Pfizer had the Lowest Relative Performance in the Pharmaceuticals Industry (PFE, NKTR, SNY, MRK, MDCO) - Financial News Network Online - News Corner
May 1, 2013 Regeneron Pharmaceuticals: The Stock That Only Goes Up? - Benzinga
May 1, 2013 Sanofi (SNY) Could Break Through $55.03 Resistance Level - Freshbrewedmedia
May 1, 2013 Sanofi Pasteur Scholarships awarded to four HEC Montr??al students - Cnw Group
May 1, 2013 Weak Data Hamstring Stocks; Regeneron Pharmaceuticals Soars - Investors Business Daily
Apr 30, 2013 3 Investment Ideas for Biotech Investors - TheMotleyFool
Apr 30, 2013 NextBio Announces Translational Medicine Partnership with Sanofi - Pr Newswire
Apr 30, 2013 What News Will Drive Amgen Stock Next? - TheMotleyFool
Apr 29, 2013 3 Biotech Companies Ripe for a Takeover - TheMotleyFool
Apr 29, 2013 Biogen Stock Hits High On Strong Tecfidera Report - Investors Business Daily
Apr 29, 2013 Biogen Stock Up on New MS Drug Sales - YCharts
Apr 29, 2013 Biogen up on Tecfidera growth - Investors Business Daily
Apr 29, 2013 Sanofi-Aventis Bullish Moving Average Crossover Alert (SNY) - Financial News Network Online - Moving Average Crossovers
Apr 29, 2013 Sanofi-Aventis Makes a Move: Up 1.7% - Financial News Network Online - Market Movers
Apr 29, 2013 Technical Briefing on SNY, VVUS, ACUR, and NSPH - Accesswire-Tnw
Apr 27, 2013 Sanofi-AventisCorporate Event Announcement Notice - Wall Street Horizon
Apr 26, 2013 Is a Pharmaceutical Company the Same as a Biotech? - TheMotleyFool
Apr 26, 2013 XenoPort had the Lowest Relative Performance in the Pharmaceuticals Industry (XNPT, BMY, SNY, QCOR, VRX) - Financial News Network Online - News Corner
Apr 25, 2013 A Peek Into The Market Before The Trading Starts - Benzinga
Apr 25, 2013 Checking in on This Ex-Lehman Hedge Fund???s Favorite Equities - TheMotleyFool
Apr 25, 2013 Genzyme Announces Positive Top-Line Results from TOPIC Trial for AUBAGIO - Benzinga
Apr 25, 2013 Once-daily AUBAGIO(R) Delayed Onset of Clinically Definite Multiple Sclerosis (MS) in TOPIC Study - Businesswire
Apr 25, 2013 Sucampo Pharmaceuticals is Among the Companies in the Pharmaceuticals Industry with the Best Relative Performance (SCMP, QCOR, TEVA, SLXP, SNY) - Financial News Network Online - News Corner
Apr 24, 2013 2 Orphan Drugmakers With Upcoming Catalysts - TheMotleyFool
Apr 24, 2013 European drug stocks are on a tear - CNNMoney
Apr 24, 2013 Sanofi Pasteur and KaloBios announces grant of Fast Track designation by US FDA for KB001A - M2
Apr 24, 2013 Shares of Sanofi-Aventis Rise Above Previous 52-Week High - Financial News Netwfork Online - 52-Week High-Lows
Apr 23, 2013 Eli Lilly Earnings Preview: EPS, Sales Growth Expected - Benzinga
Apr 23, 2013 Market Maker Surveillance Report. DELL, PFE, GE, MU, S, SNY, Highest Net Sell Volume and Negative Price Friction For Monday, April 22nd 2013 - M2
Apr 23, 2013 Sanofi-Aventis Makes a Move: Up 2.5% - Financial News Network Online - Market Movers
Apr 23, 2013 The Zacks Analyst Blog Highlights: Bristol-Myers Squibb, Sanofi, Eli Lilly, Gilead Sciences and Logitech International - Pr Newswire
Apr 23, 2013 U.S. FDA Grants Fast-Track Designation to Sanofi Pasteur and KaloBios' Novel Biologic Candidate for Pseudomonas aeruginosa - Pr Newswire
Apr 23, 2013 Will Eli Lilly`s Big Bets Pay Off? - TheMotleyFool
Apr 22, 2013 Sanofi-Aventis's Shares Changing Hands at Lower Prices on 1.6x Above-Average Volume (SNY) - Financial News Network Online - Unusual Volume
Apr 18, 2013 Genzyme Convenes 13th European Fabry Disease Roundtable - Businesswire
Apr 18, 2013 Investing in Potential Blockbusters - TheMotleyFool
Apr 18, 2013 Sanofi (SNY) Could Break Through $53.99 Resistance Level - Freshbrewedmedia
Apr 18, 2013 Short-term Underperformance Detected in Shares of Sanofi-Aventis in the Pharmaceuticals Industry (SNY, RHHBY, WCRX, NVS, NKTR) - Financial News Network Online - News Corner
Apr 18, 2013 Why Sinovac Is Poised to Keep Pulling Back - TheMotleyFool
Apr 17, 2013 3 Potential Game Changers for America`s No. 1 Killer - TheMotleyFool
Apr 17, 2013 Bearish Moving Average Cross by Sanofi-Aventis (SNY) - Financial News Network Online - Moving Average Crossovers
Apr 17, 2013 Regeneron Succeeds By Putting Science First, Says CEO - Investors Business Daily
Apr 17, 2013 Shares of Sanofi-Aventis Under Pressure, Down 2.5% - Financial News Network Online - Market Movers
Apr 16, 2013 Can These Biotechs Continue to Climb? - TheMotleyFool
Apr 16, 2013 Critical Trade Alerts For JPMorgan Chase, Sanofi-Aventis, Emerson Electric, ASML, and CarMax Released By InvestorsObserver - Pr Newswire
Apr 16, 2013 Sanofi Announces Call for Submissions for Ignite: The Diabetes Ideas Challenge - Pr Newswire Europe
Apr 16, 2013 Top 5 Companies in the Pharmaceuticals Industry with the Best Relative Performance (SNY, GSK, NVS, AKRX, OMPI) - Financial News Network Online - News Corner
Apr 15, 2013 After Yesterday's Rally of 2.65% Shares Could Potentially Pullback - Comtex Smartrend(R)
Apr 15, 2013 Look for Shares of Sanofi-Aventis to Potentially Pullback after Yesterday's 2.65% Rise - Comtex Smartrend(R)
Apr 15, 2013 Recent 52-Week High Exceeded in Shares of Sanofi-Aventis (SNY) - Financial News Netwfork Online - 52-Week High-Lows
